NCT06695767 Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
| NCT ID | NCT06695767 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Major Depressive Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 16 participants |
| Start Date | 2024-12-19 |
| Primary Completion | 2025-02-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 16 participants in total. It began in 2024-12-19 with a primary completion date of 2025-02-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to examine the feasibility and acceptability of an online group Neuro-behavioral Therapy (NBT) with text messaging intervention for Veterans with epilepsy and major depressive disorder (MDD).
Eligibility Criteria
Inclusion Criteria: * English speaking veterans * has home internet access * has access to and familiarity in using a computer or tablet at least weekly * Asymptomatic patients with chronic conditions * has access to a mobile device with Short Message Service (SMS) text and picture capability * has an active clinical diagnosis of major depressive disorder based on the International Classification of Diseases, 10th version (ICD-10) * has an ICD-10 diagnosis of epilepsy with at least one seizure documented within the last five years Exclusion Criteria: * pregnancy * Veterans that have current suicidal ideation * have active psychosis; and have an ICD-10 diagnosis of psychogenic non-epileptic seizures or conversion disorder.
Contact & Investigator
Melissa Fadipe, MSN, APRN, FNP-C
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center, Houston
Frequently Asked Questions
Who can join the NCT06695767 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Major Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06695767 currently recruiting?
Yes, NCT06695767 is actively recruiting participants. Contact the research team at Melissa.F.Fadipe@uth.tmc.edu for enrollment information.
Where is the NCT06695767 trial being conducted?
This trial is being conducted at Houston, United States, Houston, United States.
Who is sponsoring the NCT06695767 clinical trial?
NCT06695767 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Melissa Fadipe, MSN, APRN, FNP-C at The University of Texas Health Science Center, Houston. The trial plans to enroll 16 participants.